Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: UroGen Pharma Ltd., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
UroGen Pharma Ltd. June 22, 202698.6%
-
Eledon Pharmaceuticals Inc. June 18, 20260.0%
-
UroGen Pharma Ltd. August 26, 202598.9%
-
UroGen Pharma Ltd. August 6, 202499.5%
-
UroGen Pharma Ltd. September 7, 202399.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 26, 2026 | UroGen Pharma Ltd. | Option exercise | +2,000 | — | — |
| May 26, 2026 | UroGen Pharma Ltd. | Option exercise | +2,000 | — | — |
| Jan 10, 2026 | Eledon Pharmaceuticals Inc. | Option exercise | +3,430 | — | — |
| Nov 26, 2025 | UroGen Pharma Ltd. | Option exercise | +2,000 | — | — |
| Feb 26, 2025 | UroGen Pharma Ltd. | Option exercise | +2,000 | — | — |
Questions about James A. Robinson Jr.
What boards is James A. Robinson Jr. on?
James A. Robinson Jr. sits on the boards of Eledon Pharmaceuticals Inc. and UroGen Pharma Ltd.
How long has James A. Robinson Jr. served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.